Cambridge trailblazer Quantinuum has been valued at £4 billion by an equity fundraising round of around £237 million. The company’s major shareholder Honeywell, which previously invested around $325m in Quantinuum, is said to have exchanged its convertible instruments for the same class of preferred stock raised in the latest round. JPMorgan Chase, Mitsui and Amgen … Continue reading Cambridge trailblazer Quantinuum valued at £4bn